Long-term Outcome of Adult Patients With Membranous Nephropathy Treated With Rituximab

Long-term Outcome of Adult Patients With Membranous Nephropathy Treated With Rituximab

Introduction: Rituximab (RTX) therapy has become the standard of care for treatment of membranous nephropathy (MN). However, data on hard outcomes such as end-stage kidney disease (ESKD) and loss of estimated glomerular filtration rate (eGFR), are lacking. Methods: This was a retrospective study on...

Full description

Saved in:
Bibliographic Details
Main Authors: Maria J. Vargas-Brochero, Elisabeth Lafaut, Yeshwanter Radhakrishnan, Ilario Russo, Sanjeev Sethi, Ladan Zand, Daniela Valencia, Miriam Machado, Maria Jose Soler, Anila Cara, Gian Marco Berti, Daniel C. Cattran, Fernando C. Fervenza
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:Kidney International Reports
Subjects:
long-term outcome
membranous nephropathy
remission
rituximab
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024925003158
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items